118 related articles for article (PubMed ID: 37708114)
21. Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice.
Silvas JA; Vasquez DM; Park JG; Chiem K; Allué-Guardia A; Garcia-Vilanova A; Platt RN; Miorin L; Kehrer T; Cupic A; Gonzalez-Reiche AS; Bakel HV; García-Sastre A; Anderson T; Torrelles JB; Ye C; Martinez-Sobrido L
J Virol; 2021 Aug; 95(17):e0040221. PubMed ID: 34133899
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the pathogenesis of SARS-CoV-2 infection in K18-hACE2 mouse and Syrian golden hamster models.
Jeong H; Woo Lee Y; Park IH; Noh H; Kim SH; Kim J; Jeon D; Jang HJ; Oh J; On D; Uhm C; Cho K; Oh H; Yoon S; Seo JS; Kim JJ; Seok SH; Lee YJ; Hong SM; An SH; Yeon Kim S; Kim YB; Hwang JY; Lee HJ; Kim HB; Jeong DG; Song D; Song M; Park MS; Choi KS; Park JW; Seo JY; Yun JW; Shin JS; Lee HY; Nam KT; Seong JK
Dis Model Mech; 2022 Nov; 15(11):. PubMed ID: 36222118
[TBL] [Abstract][Full Text] [Related]
23. Comparison of model-specific histopathology in mouse models of COVID-19.
Yang S; Cao L; Xu W; Xu T; Zheng B; Ji Y; Huang S; Liu L; Du J; Peng H; Zhang H; Chen J; Ke B; Zheng H; Deng X; Li C; Guo D
J Med Virol; 2022 Aug; 94(8):3605-3612. PubMed ID: 35355296
[TBL] [Abstract][Full Text] [Related]
24. K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research.
Dedoni S; Avdoshina V; Camoglio C; Siddi C; Fratta W; Scherma M; Fadda P
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807384
[TBL] [Abstract][Full Text] [Related]
25. SARS-CoV-2 B.1.1.7 (alpha) and B.1.351 (beta) variants induce pathogenic patterns in K18-hACE2 transgenic mice distinct from early strains.
Radvak P; Kwon HJ; Kosikova M; Ortega-Rodriguez U; Xiang R; Phue JN; Shen RF; Rozzelle J; Kapoor N; Rabara T; Fairman J; Xie H
Nat Commun; 2021 Nov; 12(1):6559. PubMed ID: 34772941
[TBL] [Abstract][Full Text] [Related]
26. Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice.
Paull JRA; Luscombe CA; Castellarnau A; Heery GP; Bobardt MD; Gallay PA
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452519
[TBL] [Abstract][Full Text] [Related]
27. Investigation of the Antiviral Effects of Saussurea lappa Root Extract against SARS-CoV-2 Virus.
Ulbegi Polat H; Serhatli M; Taş Ekiz A; Abaci İ; Aksoy Ö; Çakirca G; Tekin Ş; Al-Zendani AAH; Al-Zendani MAA; Korkmaz Ö; Peru C
Mol Nutr Food Res; 2023 Jul; 67(14):e2200804. PubMed ID: 37170075
[TBL] [Abstract][Full Text] [Related]
28. Galectin-9 protects humanized-ACE2 immunocompetent mice from SARS-CoV-2 infection.
Yeung ST; Premeaux TA; Du L; Niki T; Pillai SK; Khanna KM; Ndhlovu LC
Front Immunol; 2022; 13():1011185. PubMed ID: 36325323
[TBL] [Abstract][Full Text] [Related]
29. Characterization of Three Variants of SARS-CoV-2 In Vivo Shows Host-Dependent Pathogenicity in Hamsters, While Not in K18-hACE2 Mice.
Toomer G; Burns W; Garcia L; Henry G; Biancofiori A; George A; Duffy C; Chu J; Sides M; Muñoz M; Garcia K; Nikolai-Yogerst A; Peng X; Westfall L; Baker R
Viruses; 2022 Nov; 14(11):. PubMed ID: 36423193
[TBL] [Abstract][Full Text] [Related]
30. Antiviral activity of oleandrin and a defined extract of Nerium oleander against SARS-CoV-2.
Plante KS; Dwivedi V; Plante JA; Fernandez D; Mirchandani D; Bopp N; Aguilar PV; Park JG; Tamayo PP; Delgado J; Shivanna V; Torrelles JB; Martinez-Sobrido L; Matos R; Weaver SC; Sastry KJ; Newman RA
Biomed Pharmacother; 2021 Jun; 138():111457. PubMed ID: 33721754
[TBL] [Abstract][Full Text] [Related]
31. Severe Acute Respiratory Syndrome Coronavirus-2 Inactivation Activity of the Polyphenol-Rich Tea Leaf Extract with Concentrated Theaflavins and Other Virucidal Catechins.
Takeda Y; Tamura K; Jamsransuren D; Matsuda S; Ogawa H
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443390
[TBL] [Abstract][Full Text] [Related]
32. Cytokines and Lipid Mediators of Inflammation in Lungs of SARS-CoV-2 Infected Mice.
Dubuc I; Prunier J; Lacasse É; Gravel A; Puhm F; Allaeys I; Archambault AS; Gudimard L; Villano R; Droit A; Flamand N; Boilard É; Flamand L
Front Immunol; 2022; 13():893792. PubMed ID: 35812400
[TBL] [Abstract][Full Text] [Related]
33. Sequential infection with H1N1 and SARS-CoV-2 aggravated COVID-19 pathogenesis in a mammalian model, and co-vaccination as an effective method of prevention of COVID-19 and influenza.
Bao L; Deng W; Qi F; Lv Q; Song Z; Liu J; Gao H; Wei Q; Yu P; Xu Y; Qu Y; Li F; Xue J; Gong S; Liu M; Wang G; Wang S; Zhao B; Cong B; Qin C
Signal Transduct Target Ther; 2021 May; 6(1):200. PubMed ID: 34016949
[TBL] [Abstract][Full Text] [Related]
34. A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta.
Carter B; Huang P; Liu G; Liang Y; Lin PJC; Peng BH; McKay LGA; Dimitrakakis A; Hsu J; Tat V; Saenkham-Huntsinger P; Chen J; Kaseke C; Gaiha GD; Xu Q; Griffiths A; Tam YK; Tseng CK; Gifford DK
Front Immunol; 2023; 14():1135815. PubMed ID: 36969239
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the Pathogenicity of SARS-CoV-2 Delta and Omicron Variants by Analyzing the Expression Patterns of Immune Response Genes in K18-hACE2 Transgenic Mice.
Kuruppuarachchi KAPP; Jang Y; Seo SH
Front Biosci (Landmark Ed); 2022 Nov; 27(11):316. PubMed ID: 36472114
[TBL] [Abstract][Full Text] [Related]
36. Assessment of aquo-ethanolic extract of Camellia sinensis against Carbapenem Resistant Escherichia coli: In Vivo Trials in a Murine Model.
Thakur P; Chawla R; Narula A; Goel R; Arora R; Sharma RK
Biomed Pharmacother; 2016 Apr; 79():273-83. PubMed ID: 27044838
[TBL] [Abstract][Full Text] [Related]
37. H1N1 exposure during the convalescent stage of SARS-CoV-2 infection results in enhanced lung pathologic damage in hACE2 transgenic mice.
Li H; Zhao X; Zhao Y; Li J; Zheng H; Xue M; Guo L; Zhou J; Yang J; Zuo Y; Chen Y; Yang Z; Fan Q; Qin L; Shi H; Liu L
Emerg Microbes Infect; 2021 Dec; 10(1):1156-1168. PubMed ID: 34060982
[No Abstract] [Full Text] [Related]
38. Korean Red Ginseng Relieves Inflammation and Modulates Immune Response Induced by Pseudo-Type SARS-CoV-2.
Kwon KW; Kim JW; Moon S; Yoon JH; Youn SH; Hyun SH; Kim HG; Kweon DH; Cho JY
Am J Chin Med; 2023; 51(6):1361-1384. PubMed ID: 37489113
[TBL] [Abstract][Full Text] [Related]
39. Virulence Profiles of Wild-Type, P.1 and Delta SARS-CoV-2 Variants in K18-hACE2 Transgenic Mice.
da Silva Santos Y; Gamon THM; de Azevedo MSP; Telezynski BL; de Souza EE; de Oliveira DBL; Dombrowski JG; Rosa-Fernandes L; Palmisano G; de Moura Carvalho LJ; Luvizotto MCR; Wrenger C; Covas DT; Curi R; Marinho CRF; Durigon EL; Epiphanio S
Viruses; 2023 Apr; 15(4):. PubMed ID: 37112979
[TBL] [Abstract][Full Text] [Related]
40. Preclinical evaluation of a plant-derived SARS-CoV-2 subunit vaccine: Protective efficacy, immunogenicity, safety, and toxicity.
Shanmugaraj B; Khorattanakulchai N; Panapitakkul C; Malla A; Im-Erbsin R; Inthawong M; Sunyakumthorn P; Hunsawong T; Klungthong C; Reed MC; Kemthong T; Suttisan N; Malaivijitnond S; Srimangkornkaew P; Klinkhamhom A; Manopwisedjaroen S; Thitithanyanont A; Taychakhoonavudh S; Phoolcharoen W
Vaccine; 2022 Jul; 40(32):4440-4452. PubMed ID: 35697573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
